Further evidence for a role of nitric oxide in experimental allergic encephalomyelitis: Aminoguanidine treatment modifies its clinical evolution

Brain Research

Volumn 855, Issue 1, 2000, Pages 39-46

  Pozza, M ^a   Bettelli, C ^a   Aloe, L ^c   Giardino, L ^a   Calza L ^a,b  

^a HESPERIA HOSPITAL   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c Institute of Neurobiology   (Italy)

Author keywords

Experimental allergic encephalomyelitis; Nitric oxide; Nitric oxide inhibitor; Rat

Indexed keywords

AMINOGUANIDINE; NITRIC OXIDE;

ACTIVE IMMUNIZATION; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME INHIBITION; FEMALE; IMMUNOPATHOGENESIS; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RELAPSE;

ACUTE DISEASE; ANIMALS; BRAIN; DEMYELINATING DISEASES; DISEASE PROGRESSION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME INHIBITORS; FEMALE; GUANIDINES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, INBRED LEW; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 0033977406     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02133-2     Document Type: Article

References (46)

1. Bagasra O., Michaels F.H., Mu Zheng Y., Bobroski L.E., Spitsin S.V., Fang Fu Z., Tawadros R., Koprowski H. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 92:1995;12041-12045.
2. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am. J. Physiol. 271:1996;C1424-C1437.
3. Bo L., Dawson T.M., Wesselingh S., Mork S., Choi S., Kong P.A., Hanley D., Trapp B.D. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36:1994;778-786.
4. Boje K.M.K. Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis. Brain Res. 720:1996;75-83.
5. Brenner T., Brocke S., Szafer F., Sobel R.A., Parkinson J.F., Perez D.H., Steinman L. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J. Immunol. 158:1997;2940-2946.
6. Calzà L., Giardino L., Pozza M., Micera A., Aloe L. Time-course changes of nerve growth factor, corticotropin-releasing hormone, and nitric oxide synthase isoforms and their possible role in the development of inflammatory response in experimental allergic encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A. 94:1997;3368-3373.
7. Clancy R.M., Amin A.R., Abramson S.B. The role of nitric oxide in inflammation and immunity. Arthritis Rheum. 41:1998;1141-1151.
8. Cowden W.B., Cullen F.A., Staykova M.A., Willenborg D.O. Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE. J. Neuroimmunol. 88:1998;1-8.
9. Cross A.H., Misko T., Lin R., Hickey W., Trotter J., Tilton R. Aminoguanidine, an inhibitor of inducible nitric oxide synthase ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93:1994;2684-2690.
10. Cross A.H., Keeling R.M., Goorha S., San M., Rodi C., Wyatt P., Manning P.T., Misko T.P. Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis. J. Neuroimmunol. 71:1996;145-153.
11. Dhabhar F.S., Miller A.H., McEwen B.S., Spencer R.L. Differential activation of adrenal steroid receptors in neural and immune tissues of Sprague Dawley, Fischer 344, and Lewis rats. J. Neuroimmunol. 56:1995;77-90.
12. De Vries H.E., Kuiper J., De Boer A.G., Van Berkel T.J.C., Breimer D.D. The blood-brain barrier in neuroinflammatory diseases. Pharmacol. Rev. 49:1997;143-155.
13. Ding M., Zhang M., Wong J.L., Rogers N.E., Ignarro L.J., Voskuhl R.R. Cutting edge: antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice. J. Immunol. 160:1998;2560-2564.
14. Duckers H.J., Van Dokkum R.P., Verhaagen J., Lopes da Silva F.H., Gispen W.H. Functional and neurophysiological evidence of the efficacy of trophic pharmacotherapy using an adrenocorticotrophic hormone 4-9 analog in experimental allergic encephalomyelitis, an animal model of multiple sclerosis. Neuroscience. 71:1996;507-521.
15. Duckers H.J., Muller H.J., Verhaagen J., Nicolay K., Gispen W.H. longitudinal in vivo magnetic resonance imaging studies in experimental allergic encephalomyelitis: effect of a neurotrophic treatment on cortical lesion development. Neuroscience. 77:1997;1163-1173.
16. Farrell A.J., Blake D.R. Nitric oxide. Ann. Rheum. Dis. 55:1996;7-20.
17. Fenyk-Melody J.E., Garrison A.E., Brunnert S.R., Weidner J.R., Shen F., Shelton B.A., Mudgett J.S. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 160:1998;2940-2946.
18. Garcion E., Nataf S., Berod A., Darcy F., Brachet P. 1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Mol. Brain Res. 45:1997;255-267.
19. Gold D.P., Schroder K., Powell H.C., Kelly C.J. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis. Eur. J. Immunol. 27:1997;2863-2869.
20. Hickey W.F., Gonatas N.K., Kimura H., Wilson D.B. Identification and quantitation of T lymphocyte subset found in the spinal cord of the Lewis rat during acute experimental allergic encephalomyelitis. J. Immunol. 131:1983;2805-2809.
21. Hickey W.F., Cohen J.A., Burns J.B. A quantitative immunohistochemical comparison of actively versus adoptively induced experimental allergic encephalomyelitis in the Lewis rat. Cell. Immunol. 109:1987;272-282.
22. Hooper D.C., Bagasra O., Marini J.C., Zborek A., Ohnishi S.T., Kean R., Champion J.M., Sarker A.B., Bobroski L., Farber J.L., Akaike T., Koprowski H. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 94:1997;2528-2533.
23. Hooper D.C., Spitsin S., Kean R.B., Champion J.M., Dickson G.M., Chaudhry I., Koprowski H. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 95:1998;675-680.
24. Hua L.L., Liu J.S., Brosnan C.F., Lee S.C. Selective inhibition of human glial inducible nitric oxide synthase by interferon-beta: implications for multiple sclerosis. Ann. Neurol. 43:1998;384-387.
25. Kaprowski H., Mu Zheng Y., Heber-Katz E., Fraser N., Rorke L., Fu Z.F., Hanlon C., Dietzchold B. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc. Natl. Acad. Sci. U.S.A. 90:1993;3024-3027.
26. Laskin J.D., Heck D.E., Laskin D.L. Multifunctional role of nitric oxide in inflammation. Trends Endocrinol. Metab. 5:1994;377-382.
27. Lorentzen J.C., Issazadeh S., Storch M., Mustafa M.I., Lassman H., Linington C., Klareskog L., Olsson T. Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngenic spinal cord and incomplete Freund's adjuvant. J. Neuroimmunol. 63:1995;193-205.
28. Lorentzen J.C., Andersson M., Issazadeh S., Dahlman I., Luthman H., Weissert R., Olsson T. Genetic analysis of inflammation, cytokine mRNA expression and disease course of relapsing experimental autoimmune encephalomyelitis in DA rats. J. Neuroimmunol. 80:1997;31-37.
29. Mason D. Genetic variation in the stress response: susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory disease. Immunol. Today. 12:1991;57-60.
30. Mitrovic B., Ignarro L.J., Montestruque S., Smoll A., Merrill J.E. Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience. 61:1994;575-585.
31. Okuda Y., Nakatsuji Y., Fujimura H., Esumi H., Ogura T., Yanagihara T., Sakoda S. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol. 62:1995;103-112.
32. Okuda Y., Sakoda S., Fujimura H., Yanagihara T. Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 73:1997;107-116.
33. Okuda Y., Sakoda S., Fujimura H., Yanagihara T. Aminoguanidine, a selective inhibitor of the inducible nitric oxide synthase, has different effects on experimental allergic encephalomyelitis in the induction and progression phase. J. Neuroimmunol. 81:1998;201-210.
34. Oleszak E.L., Zaczynska E., Bhattacharjee M., Butunoi C., Legido A., Katsetos C.D. Inducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not chronic, multiple sclerosis. Clin. Diagn. Lab. Immunol. 5:1998;438-445.
35. Popovich P.G., Wei P., Stokes B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 377:1997;443-464.
36. Pozza M., Bettelli C., Magnani F., Mascia M.T., Manzini E., Calzà L. Is neuronal nitric oxide involved in adjuvant-induced joint inflammation? Eur. J. Pharmacol. 359:1998;87-93.
37. Ruuls S.R., Van Der Linden S., Sontrop K., Huitinga I., Dijkstra C.D. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin. Exp. Immunol. 103:1996;467-474.
38. Sahrbacher U.C., Lechner F., Eugster H.-P., Frei K., Lassmann H., Fontana A. Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur. J. Immunol. 28:1998;1332-1338.
39. Scott G.S., Williams K.I., Bolton C. A pharmacological study on the role of nitric oxide in the pathogenesis of experimental allergic encephalomyelitis. Inflamm. Res. 45:1996;524-529.
40. Smith K.J., Kapoor R., Felts P.A. Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol. 9:1999;69-92.
41. Snyder S.H. Janus faces of nitric oxide. Nature. 364:1993;577.
42. Sternberg E.M., Young W.S. III, Bernardini R., Calogero A.E., Chrousos G.P., Gold P.W., Wilder R.L. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc. Natl. Acad. Sci. U.S.A. 86:1989;4771-4775.
43. Vladimirova O., O'Connor J., Cahill A., Alder H., Butunoi C., Kalman B. Oxidative damage to DNA in plaques of MS brains. Mult. Scler. 4:1998;413-418.
44. Zhao W., Tilton R.G., Corbett J.A., McDaniel M.L., Misko T.P., Williamson J.R., Cross A.H., Hickey W.F. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J. Neuroimmunol. 64:1996;123-133.
45. Zielasek J., Jung S., Gold R., Liew F., Toyka K., Hartung H. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58:1995;81-88.
46. Xiao B.G., Bail X.F., Zhang G.X., Hedlund G., Link H. Linomide-mediated protection of oligodendrocytes is associated with inhibition of nitric oxide production and IL-1beta expression in Lewis rat glial cells. Neurosci. Lett. 249:1998;17-20.